Clinical trial
Investigational TMS Study of Cognitive Impairment in Early Psychosis
NCT05857137 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigational TMS Study of Cognitive Impairment in Early Psychosis
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 4, 2023
- Completion date
- June 30, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
psychosis